Literature DB >> 9029532

Comparison between cytomegalovirus promoter and elongation factor-1 alpha promoter-driven constructs in the establishment of cell lines expressing hepatitis C virus core protein.

K Tokushige1, D Moradpour, T Wakita, M Geissler, N Hayashi, J R Wands.   

Abstract

The establishment of stable cell lines expressing the hepatitis C virus (HCV) core protein may be important for studies of HCV pathogenesis. Human and mouse cell lines were generated expressing the HCV core protein using expression vectors driven by either the cytomegalovirus (CMV) or elongation factor-1 alpha (EF-1 alpha) promoters. Following transient transfection, HCV core protein was expressed in all cell lines. However, stable human hepatocellular carcinoma (HCC) and murine myeloma cell lines expressing the HCV core protein were only established using constructs driven by the EF-1 alpha promoter. In contrast, stable expression of the hepatitis B virus (HBV) middle envelope protein (MHBs) was obtained successfully in these cell lines using an expression vector driven by the CMV promoter. Inhibitory activity of the first 69 amino acids of the HCV core protein on the CMV promoter was found by using chimeric MHBs/HCV core protein constructs. Growth of cloned cell lines expressing the HCV core protein was slower than that of nonexpressing cell lines. However, morphological changes and cell death were not observed in the stable cell lines expressing HCV core protein. These results indicate that the HCV core protein was not directly cytotoxic to HCC and myeloma cell lines but that specific promoter elements are required to establish stable expression of the nucleocapsid structural protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9029532     DOI: 10.1016/s0166-0934(96)02143-x

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  10 in total

1.  Lentiviral mediated gene delivery to the anterior chamber of rodent eyes.

Authors:  Pratap Challa; Coralia Luna; Paloma B Liton; Beth Chamblin; John Wakefield; Ram Ramabhadran; David L Epstein; Pedro Gonzalez
Journal:  Mol Vis       Date:  2005-06-21       Impact factor: 2.367

2.  Comparison of HCMV IE and EF-1 promoters for the stable expression of beta-subunit of hexosaminidase in CHO cell lines.

Authors:  Incilay Sinici; Maryam Zarghooni; Michael B Tropak; Don J Mahuran; H Asuman Ozkara
Journal:  Biochem Genet       Date:  2006-04-28       Impact factor: 1.890

3.  Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1.

Authors:  H Aoki; J Hayashi; M Moriyama; Y Arakawa; O Hino
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  The hippo pathway effector Yap controls patterning and differentiation of airway epithelial progenitors.

Authors:  John E Mahoney; Munemasa Mori; Aleksander D Szymaniak; Xaralabos Varelas; Wellington V Cardoso
Journal:  Dev Cell       Date:  2014-07-17       Impact factor: 12.270

5.  Lentiviral Based Gene Transduction and Promoter Studies in Human Hematopoietic Stem Cells (hHSCs).

Authors:  N Varma; B Janic; M Ali; Asm Iskander; A Arbab
Journal:  J Stem Cells Regen Med       Date:  2011-04-01

6.  Constitutive Gs activation using a single-construct tetracycline-inducible expression system in embryonic stem cells and mice.

Authors:  Edward C Hsiao; Trieu D Nguyen; Jennifer K Ng; Mark J Scott; Wei Chun Chang; Hengameh Zahed; Bruce R Conklin
Journal:  Stem Cell Res Ther       Date:  2011-03-04       Impact factor: 6.832

7.  Promoter, transgene, and cell line effects in the transfection of mammalian cells using PDMAEMA-based nano-stars.

Authors:  Alexander Raup; Valérie Jérôme; Ruth Freitag; Christopher V Synatschke; Axel H E Müller
Journal:  Biotechnol Rep (Amst)       Date:  2016-06-16

8.  Generation of a genome scale lentiviral vector library for EF1α promoter-driven expression of human ORFs and identification of human genes affecting viral titer.

Authors:  Dubravka Škalamera; Mareike Dahmer; Amy S Purdon; Benjamin M Wilson; Max V Ranall; Antje Blumenthal; Brian Gabrielli; Thomas J Gonda
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

9.  Establishment of clonal MIN-O transplant lines for molecular imaging via lentiviral transduction & in vitro culture.

Authors:  David L Boucher; Jane Qian Chen; Simon R Cherry; Alexander D Borowsky
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

Review 10.  Non-Viral in Vitro Gene Delivery: It is Now Time to Set the Bar!

Authors:  Nina Bono; Federica Ponti; Diego Mantovani; Gabriele Candiani
Journal:  Pharmaceutics       Date:  2020-02-21       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.